Carclo Diagnostic Solutions Ltd - Product Pipeline Analysis

Carclo Diagnostic Solutions Ltd - Product Pipeline Analysis

Carclo Diagnostic Solutions Ltd (CDS) is a technology developer for in-vitro diagnostics industry. The company develops proof-of-concept and microfluidic technologies. CDS develops disposable devices to perform assays in a non-laboratory location. The company\'s devices comprise micropoc-cat, micropoc-lite and micropoc-pro.Micropoc-lite has applications to test blood group and for allergies; micropoc-cat has applications in blood coagulation; and micropoc-pro is helpful to detect fluorescence. It uses Conductive Inkjet Technology Ltd\'s electronics operations; and it manufactures microfluidic diagnostic devices through Carclo Technical Plastics (CTP) which has manufacturing facilities in in the UK, Czech Republic, the US, India and China. CTP manufactures equipments for electronics, healthcare and lighting industries. CDS is a subsidiary of Carclo plc. CDS is headquartered in Ossett, West Yorkshire, the UK.

This report is a source for data, analysis and actionable intelligence on the Carclo Diagnostic Solutions Ltd portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.

Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.

Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.

Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.

Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.